Flywire Heads Into Earnings With Shorts Steady and Options Defensively Skewed
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Flywire enters its November 3 earnings call with a stock that has quietly recovered, up 13% over the past month to $19.40, but with a positioning setup that tells a more cautious story underneath the price action.
The most striking feature right now is the options market. Put/call ratio has jumped sharply since mid-October, from around 6.5 to 7.44 this week, approaching the 52-week high of 7.51 hit on October 19. That reading is 1.7 standard deviations above the 20-day mean of 6.80, reflecting heavy demand for downside protection relative to calls. The contrast with mid-September is stark: the PCR was below 2.5 as recently as September 18, meaning the current defensive skew is not a structural feature of this stock but a deliberate pre-earnings lean by options traders.
Short interest at 10.6% of free float is meaningfully high, and it has been grinding steadily higher since late September, adding roughly 8% in aggregate over the past month. The borrow market, however, does not show signs of stress. Availability is generous at 387%, meaning nearly four shares are available to borrow for every one already shorted, and the cost to borrow has eased to around 0.49%, down 9% on the week. The ORTEX short score has edged higher, reaching 65.3 on October 22, its highest reading of the past two weeks, but this is a reflection of rising short interest rather than any tightening in the lending market. Overall, the positioning reads as short sellers leaning in cautiously but without urgency.
The Street remains divided in a familiar pattern for mid-cap payments names. The consensus sits at hold, with seven analysts there and the mean target around $21, modest upside from the current price. The more constructive voices, including RBC Capital with a $25 target and B. Riley at $24, both carry Outperform or Buy ratings and point to the company's diversification away from its old dependence on cross-border education. Revenue from travel and healthcare verticals has grown, and bulls note Q1 2026 revenue grew 37% on a constant-currency basis with adjusted EBITDA beating expectations. Bears counter that UK education exposure has deteriorated, with early-season visa applications running roughly 30% below the prior year, and that management's FY27 guidance implied a modest step-down in gross margin. Stephens reinstated coverage at Equal-Weight with a $20 target on October 16, essentially marking the stock as fairly valued at current levels. Goldman Sachs remains Neutral, having lifted its target to $20 from $17 back in July. Factor scores add nuance: EPS momentum over 30 and 90 days ranks in the 87th and 90th percentiles respectively, a strong signal, but the short score rank sits in just the 8th percentile, meaning the stock is more heavily shorted than most of its peers on the ORTEX universe.
Ownership tells an interesting structural story. Voss Capital holds 11.3% of shares and is the largest reported holder by a clear margin, with its 13G/A filing showing the stake grew from 10.25% to 12.1% through April of this year. BlackRock and Wasatch Advisors both added meaningfully in recent periods, with Wasatch reporting a 2.8 million share addition as of September 30. On the other side, Cadian Capital trimmed nearly 874,000 shares and Temasek has pared its holding from 5.1% to 3.5%. On the insider side, nearly all the recent Form 4 activity involves pre-planned 10b5-1 disposals: the CEO sold $2.1 million of stock in September under a plan, and other executives filed routine plan-based sales. Net insider activity over the past 90 days shows net disposals of around 915,000 shares worth roughly $17 million, but the planned nature of most of those transactions limits the informational content.
Wikipedia views for Flywire are running at a z-score of 5.5 against its own 90-day history, an unusually sharp spike in retail attention as of October 19. This is a measure of web visibility, not a revenue signal, but the timing ahead of a nine-day-away earnings print is worth noting.
The historical earnings reaction provides the clearest single piece of context. The last print, on August 4, drove a 12.1% one-day gain and a further 5% over five days. That move came with revenue well ahead of expectations. Whether the setup is as clean this time, given the softer UK education backdrop and the heavier options hedging, is the question the November 3 release will answer.
Stocks in this article
See the live data behind this article on ORTEX.
Open FLYW on ORTEX →How this article was generated
- Generated
- 25 Oct 2026, 17:33
- Data as of
- 25 Oct 2026, 17:32
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.